AbSci

2:45 PM - 3:00 PM, Monday, June 3, 2019 ・ Theater 3
AbSci is a global leader in biomanufacturing technologies. Its patented SoluPro™ expression platform rapidly produces complex proteins, ranging from mAbs, Fabs, enzymes, hormones and peptides to the most novel classes of biotherapeutics, at high-titers and high-quality. AbSci's unique approach increases discovery throughput, accelerates development, reduces manufacturing costs, and increase plant capacity for the biopharmaceutical industry.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
United States
Year Founded:
2011
Main Therapeutic Focus:
Lead Product in Development:
SoluPro
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.